Dynavax names Pfizer veteran as board member
This article was originally published in Scrip
Executive Summary
Berkeley, California-based, clinical-stage biopharmaceutical company Dynavax Technologies, has appointed Natale Ricciardi to its board of directors, effective from 8 July 2013. Mr Ricciardi previously spent 39 years working for Pfizer before retiring in 2011 – in his time at the firm he held several executive positions including president, Pfizer global manufacturing, and senior vice-president of the company. He currently sits on the board of the 21st Century Foundation of the City College of New York.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.